Skip to content
Toggle Navigation
Why Quantum
Quantum Computing Today
Quantum vs. Traditional Screening
Quantum Computing vs. AI
QuADD Solutions
Hits & Leads
Joint Development
Pipeline
Platform
Who We Serve
Pharma
Biotech
Agriculture
CROs
Resources
Blog
Whitepapers
Webinars
Publications
Company
About Us
Customers
Partners
News
Team
Contact Us
Toggle Navigation
Why Quantum
Quantum Computing Today
Quantum vs. Traditional Screening
Quantum Computing vs. AI
QuADD Solutions
Hits & Leads
Joint Development
Pipeline
Platform
Who We Serve
Pharma
Biotech
Agriculture
CROs
Resources
Blog
Whitepapers
Webinars
Publications
Company
About Us
Customers
Partners
News
Team
Contact Us
Investment
September 30th, 2021
·
1.3 min
·
PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million
PolarisQB, the Durham based developer of the world’s first drug discovery software
Search
Search for:
Recent Posts
Sextant: A New Tool for Designing Custom Molecular Templates for Protein-Protein Interaction Inhibitor Drug Design
November 10, 2024
Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets
October 18, 2024
PolarisQB Joins OpenFold AI Consortium along with Congruence, Biogen, Psivant and Others
September 20, 2024
Categories
Blog (12)
News (40)
Page load link
Go to Top